Sandoz übernimmt Antibiotika-Produktionsbetrieb
11. Dezember 2003 01:30 ET
|
Novartis Pharma AG
Sandoz übernimmt Antibiotika-Produktionsbetrieb in Spanien
Akquisition stärkt unternehmensinterne Produktion und bringt Ergänzung in der Gefriertrocknungs-Technologie
Wien/Kundl, ...
Novartis honors scientists
09. Dezember 2003 03:40 ET
|
Novartis Pharma AG
Novartis honors scientists for outstanding contributions
Top internal scientific award goes to chemist involved in Glivec® discovery
Basel, 9 December 2003 - Novartis today honors 10...
New Data Show Higher Dosing of Gleevec Achieved Higher Response Rates in Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML)
08. Dezember 2003 03:00 ET
|
Novartis Pharma AG
Early Findings Among Clinical Research Presented at American Society of Hematology (ASH) Meeting; At 12 months, 92% of evaluable CML patients taking 800 mg Gleevec achieved a CCR compared to 72%...
Post-tamoxifen Use Of Femara In Postmenopausal Women With Early Breast Cancer Reduced Risk Of Recurrence By Nearly Half (43%) and Significantly Improved Disease-Free Survival, According to Data Presented at Major Medical Meeting
08. Dezember 2003 03:00 ET
|
Novartis Pharma AG
Extended adjuvant data presented at San Antonio Breast Cancer Symposium supported by new data on quality of life with Femara vs. placebo, from same clinical trialEast Hanover, NJ, December 5, 2003 -...